000 | 01903 a2200517 4500 | ||
---|---|---|---|
005 | 20250514000142.0 | ||
264 | 0 | _c20010614 | |
008 | 200106s 0 0 eng d | ||
022 | _a0014-4827 | ||
024 | 7 |
_a10.1006/excr.2001.5198 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpisni, E | |
245 | 0 | 0 |
_aColocalization prostacyclin (PGI2) synthase--caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. _h[electronic resource] |
260 |
_bExperimental cell research _cMay 2001 |
||
300 |
_a31-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xmetabolism |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 | _aCaveolin 1 |
650 | 0 | 4 |
_aCaveolins _xmetabolism |
650 | 0 | 4 |
_aCells, Cultured _xcytology |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
650 | 0 | 4 |
_aEpoprostenol _xbiosynthesis |
650 | 0 | 4 |
_aFilipin _xpharmacology |
650 | 0 | 4 |
_aFluorescent Antibody Technique _xmethods |
650 | 0 | 4 |
_aGold Compounds _xpharmacokinetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracellular Membranes _xenzymology |
650 | 0 | 4 |
_aIntramolecular Oxidoreductases _xmetabolism |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aOctoxynol _xpharmacology |
650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xmetabolism |
650 | 0 | 4 |
_aSubcellular Fractions _xenzymology |
700 | 1 | _aGriffoni, C | |
700 | 1 | _aSanti, S | |
700 | 1 | _aRiccio, M | |
700 | 1 | _aMarulli, R | |
700 | 1 | _aBartolini, G | |
700 | 1 | _aToni, M | |
700 | 1 | _aUllrich, V | |
700 | 1 | _aTomasi, V | |
773 | 0 |
_tExperimental cell research _gvol. 266 _gno. 1 _gp. 31-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/excr.2001.5198 _zAvailable from publisher's website |
999 |
_c11272836 _d11272836 |